Heart Failure Medications- Part Three: Add-on Agents. Lecture for Pharmacy Students & Pharmacists.

In part three of this four-part lecture on Heart Failure medications, we will:
• State which type of heart failure patient will benefit most from the addition of ivabradine based on the Shift trial.
• Explain why vasopressin receptor antagonists are not recommended for heart failure patients.
• Identify which group of patients would benefit most from the addition of hydralazine/isosorbide.
• Define the current role of the use of digoxin and diuretics in heart failure.